Regulation of Renal Hemodynamics and the Nitric Oxide-Arginine Pathway

Journal of Veterinary Emergency and Critical Care

Volumn 8, Issue 1, 1998, Pages 7-18

  Rieser, Teresa M ^a   Otto, Cynthia M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Arginine; Feedback; Hemodynamics; Kidney; Nitric; Oxide; Tubuloglomerular

Indexed keywords

EID: 13544275368     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1111/j.1476-4431.1998.tb00130.x     Document Type: Article

References (54)

1. Evans HE. and Christensen GC. The Urogenital System. Evans, In: Anatomy of the Dog. Philadelphia, W.B. Saunders, 1993, pp 494–558.
2. Dworkin LD and Brenner BM. The Renal Circulations. Brenner, B. M. and Rector, F. C. The Kidney. 4(5), 164–204. 1991. Philadelphia, W.B.Saunders.
3. DiBartola SP and Rutgers HC. Diseases of the Kidney. Sherding, R. G. The Cat: Diseases and Clinical Management. 2(50), 1711–1767. 1994. Philadelphia, W.B. Saunders.
4. Ganong WF. Renal Function & Micturition. Ganong, W. F. Review of Medical Physiology. 17(38), 641–669. 1995. Norwalk, Connecticut, Appleton & Lange.
5. Guyton AC, Hall JE. Urine formation by the Kidneys:I. Glomerular Filtration, Renal Blood Flow, and Their Control. Text-book of Medical Physiology. 9(26), 315–330. 1996. Philadelphia, W.B.Saunders.
6. Pons M, Cambar J, Waterhouse JM. Renal hemodynamic mechanisms of blood pressure rhythms. [Review] [66 refs]. Annals.of.the.New York.Academy.of.Sciences. 1996 Aug. 15. 783,95 112XX<8>. 1997.
7. Navar LG, Evan AP, Rosivall L. Microcirculation of the Kidneys. Mortillaro, N. A. The Physiology and Pharmacology of the Microcirculation. 1(9), 397–488. 1983. New York, Academic Press. Physiologic and Pharmacologic Bases of Drug Therapy. Greenberg, S. and Glenn, T. M.
8. Badeer HS, Petzel DH. Glomerular vascular resistance to blood flow: a brief review [editorial]. [Review] [27 refs]. American.Journal.of.Nephrology. 1995. 15, 93–8XX<15>. 1997.
9. Nissen OI, Galskov A. Direct measurement of superficial and deep venous flow in the cat kidney. Effects of epinephrine, angiotensin, microspheres, and renal nerve stimulation. Circulation Research.1972.Jan. 30, 82–96. 1972.
10. Navar LG, Inscho EW, Majid SA, Imig JD, Harrison Bernard LM, and Mitchell KD. Paracrine regulation of the renal microcirculation.[Review][1214refs].Physiological.Reviews. 1996. Apr. 76, 425–536XX<10>. 1997.
11. Barajas L. Cell-specific protein and gene expression in the juxtaglomerular apparatus. Clin Exp Phar. 24: 520–526. 1997.
12. Brezis, M and Rosen S. Hypoxia of the renal medulla- its implications for disease. The New England Journal of Medicin. 332(10), 647–655. 1995.
13. Goligorsky MS, Iijima K, Krivenko Y. Role of mesangial cells in macula densa to afferent arteriole information transfer. Clin Phar. 24:527–531. 1997.
14. Ito S and Abe K. Contractile properties of afferent and efferent arterioles. Clin Exp Phar. 24: 532–535. 1997.
15. Briggs JP. and Schnermann JB. Whys and wherefores of juxtaglomerular apparatus function. Kidney International. 1996 Jun. 49, 1724–1726. 1996.
16. Welch WJ and Wilcox CS. Role of nitric oxide in tubuloglomerular effects of dietary salt. Clin Exp Phar. 24: 582–586. 1997.
17. Ito S and Ren Y. Evidence for the role of nitric oxide in macula densa control of glomerular hemodynamics. J.Clin.Invest. 92(2), 1093–1098. 1993.
18. Kurtz A. Membrane and Secretory properties of renal juxtaglomerular granular cells. Clin Exp Phar. 24: 536–540. 1997.
19. Maddox DM. and Brenner BM. Glomerular Ultrafiltration. Brenner, B. M. and Rector, F. C. The Kidney. 4(6), 205–244. 1991. Philadelphia, W.B. Saunders.
20. Furchgott RF and Zawadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Natur. 288, 373–376. 1980.
21. Busse R, Mülsch A, Fleming I, and Hecker M. Mechanisms of nitric oxide release from the vascular endothelium. Circulatio. 87(Suppl. V), V-18–V-25. 1993.
22. Ekelund U and Mellander S. Role of endothelium-derived nitric oxide in the regulation of tonus in large-bore arterial resistance vessels, arterioles and veins in cat skeletal muscle. Acta Physiologica. Scandinavica Nov 1990. 140, 301–309. 1990.
23. Moncada S and Higgs A. The L-arginine-nitric oxide pathway. [Review] [120 refs]. New England. Journal. of. Medicine Dec. 30 1993. 329, 2002–2012. 1997.
24. Moncada S, Palmer RM and Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. [Review] [404 refs]. Pharmacological. Reviews. 1991 Jun. 43, 109–42XX. 1997.
25. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6(September), 3051–3064. 1992.
26. Star RA. Intrarenal localization of nitric oxide synthase isoforms and soluble guanylyl cyclase. Clin Exp Phar. 24: 607–610. 1997.
27. Ito S, Carretero OA, and Abe K. Role of nitric oxide in the control of glomerular circulation. Clin Exp Phar. 24: 578–581. 1997.
28. Stamler JS, Singel DJ, and Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Scienc. 258, 1898–1902. 1992.
29. Bachmann S and Mundel P. Nitric oxide in the kidney: synthesis, localization, and function. [Review] [168 refs]. American.Journal.of.Kidney Diseases.1994.Jul. 24, 112–29XX<9>. 1997.
30. Fukuto JM. Chemistry of nitric oxide: biologically relevant aspects. [Review] [36 refs]. Advances in Pharmacology 1995. 34, 1–15XX. 1997.
31. Moshage H, Kok B, Huizenga JR, and Jansen PL. M. Nitrite and nitrate determinations in plasma: a critical evaluation. Clin.Chem. 41(6), 892–896. 1995.
32. Kone BC and Baylis C. Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am.J.Physiol. 272(Renal Physiol. 41), F561–F578. 1997.
33. Palmer RMJ, Ashton DS and Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Natur. 333(16 June), 664–666. 1988.
34. Bouby N, Hassler C, Parvy P, and Bankir L. Renal synthesis of arginine in chronic renal failure: in vivo and in vitro studies in rats with 5/6 nephrectomy. Kidney Int. 44, 676–683. 1993.
35. Levillain O, Hus-Citharel A, Morel F, and Bankir L. Arginine synthesis in mouse and rabbit nephron: localization and functional significance. Am.J.Physiol. 264(Renal Fluid 33), F1038–F1045. 1993.
36. Reyes AA, Karl IE, and Klahr S. Role of arginine in health and in renal disease. Am.J.Physiol. 267(Renal Fluid 36), F331–F346. 1994.
37. Rogers QR and Morris JG. Essentiality of amino acids for the growing kitten. J.Nutr. 109, 718–723. 1979.
38. Stewart PM, Batshaw M, Valle D, and Walser M. Effects of arginine-free meals on ureagenesis in cats. American.Journal.of.Physiolog. 241 (Endocrinol. Metab 4), E310–E315. 1981.
39. Bellan JA, McNamara DB, and Kadowitz PJ. Differential effects of nitric oxide synthesis inhibitors on vascular resistance and responses to acetylcholine in cats. American. Journal of Physiology. 264, H45–H52. 1993.
40. Wakabayashi Y, Yamada E, Yoshida T, and Takahashi H. Deficiency of endogenous arginine synthesis provokes hypertension by exhausting substrate arginine for nitric oxide synthesis. Biochemical and Biophysical Research Communication. 205(2), 1391–1398. 1994.
41. Xia Y, Dawson VL, Dawson TM, Snyder SH, and Zweier JL. Nitric oxide synthase generates superoxide and nitric oxide in arginine depleted cells leading to peroxynitrite-mediated cellular injury. Proc.Natl.Acad.Sci.US. 93, 6770–6774. 1996.
42. Ischiropoulos H and Al-Mehdi AB. Peroxynitrite-mediated oxidative protein modifications. FEBS Letter. 364, 279–282. 1995.
43. Crow JP and Beckman JS. The role of peroxynitrite in nitric oxide-mediated toxicity. [Review] [75 refs]. Current.Topics.in Microbiology.&.Immunolog. 1995. 57–73XX. 1997.
44. Schroeder RA and Kuo PC. Nitric oxide: physiology and pharmacology. Anesth Analg. 81, 1052–1059. 1995.
45. Lowenstein CJ and Snyder SH. Nitric oxide, a novel biologic messenger. Cel. 70, 705–707. 1992.
46. Baylis C and Qiu C. Importance of nitric oxide in the control of renal hemodynamics. [Review] [36 refs]. Kidney International.1996.Jun. 49, 1727–31XX<15>. 1997.
47. Ito S, Arima S, Ren Y, Juncos LA and Carretero OA. Endothelium-derived Relaxing Factor/Nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole. J.Clin.Invest. 91, 2012–2019. 1993.
48. Lahera V, Navarro-Cid J, Cachofeiro V, Garcia-Estan J, and Ruilope LM. Nitric oxide, the Kidney, and hypertension. [Review] [101 refs]. American.Journal.of.Hypertension 1997.Jan. 10, 129–140. 1997.
49. Sigmon DH and Bierwaltes WH. Nitric oxide influences blood flow distribution in renovascular hypertension. Hypertensio. 23(1 Suppl I), I–34 I–39. 1994.
50. Bosse HM, Bohm R, Resch S, and Bachmann S. Parallel regulation of constitutive No synthase and renin at JGA of rat kidney under various stimuli. Am.J.Physiol. 269(Renal Fluid), F793–F805. 1995.
51. Ito S, Carretero OA, and Abe K. Nitric oxide in the regulation of renal blood flow. [Review] [68 refs]. New Horizons.1995.Nov. 3, 615–23XX<11>. 1997.
52. Levin ER. Endothelins. [Review] [89 refs]. New England.Journal.of.Medicine 1995.Aug.10. 333, 356–63XX. 1997.
53. Fujita K, Matsumura Y, Miyazaki Y, Takaoka M, and Morimoto S. Role of endothelin-1 in hypertension induced by long-term inhibition of nitric oxide synthase. European Journal of Pharmacolog. 280, 311–316. 1995.
54. Owada A, Tomita K, Sakamoto H, Nonoguchi H, and Marumo F. Endothelin (ET)-3 stimulates cyclic guanosine 3', 5'- monophosphate production via ETB receptor by producing nitric oxide in isolated rat glomerulus, and in cultured rat mesangial cells. J.Clin.Invest. 93(2), 556–563. 1994.